Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 16
Selected: 0
NCT IDTitle
NCT03785964Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
NCT03962543MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas
NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
NCT02955446Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
NCT06843967A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
NCT03905148Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors
NCT05041036Individual Patient Compassionate Use of Nirogacestat
NCT05580770Mirdametinib + BGB-3245 in Advanced Solid Tumors
NCT04195399A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
NCT05949099Study of Cryoablation and Nirogacestat for Desmoid Tumor
NCT05348356Nirogacestat in Ovarian Granulosa Cell Tumors
NCT06159166Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
NCT04923126SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
NCT05028166Individual Patient Compassionate Use of Mirdametinib
NCT06997276Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib
NCT06251310SW-682 in Advanced Solid Tumors